Leukemias
ల్యూకేమియాస్
Diagnosis and treatment of acute and chronic leukemias including AML, ALL, CML, and CLL.
ల్యూకేమియా (రక్త క్యాన్సర్) చికిత్సలో అనుభవం.
I'm a Medical Oncologist, Hemato-Oncologist and Bone Marrow Transplant Physician currently practicing at Omega Hospitals, Gachibowli and Peoples Polyclinic, Manikonda, Hyderabad. I specialize in bone marrow transplantation, blood cancer treatment, and comprehensive oncology services. My work has been featured in national media and television programs.
My journey in oncology began at Nizam's Institute of Medical Sciences (NIMS), Hyderabad where I completed my DM in Medical Oncology. I further trained at Vancouver General Hospital, Canada, one of North America's premier centers for hematologic cancers and stem cell transplantation.
My expertise also includes CAR T-cell therapy and advanced immunotherapies for blood and solid cancers.
For TV and press appearances, see my Media page. For guidance on choosing an oncologist in Hyderabad, see Best Oncologist in Hyderabad.
Diagnosis and treatment of acute and chronic leukemias including AML, ALL, CML, and CLL.
ల్యూకేమియా (రక్త క్యాన్సర్) చికిత్సలో అనుభవం.
Comprehensive care for Hodgkin and Non-Hodgkin lymphomas with advanced protocols.
లింఫోమా చికిత్సలో ప్రత్యేక నైపుణ్యం.
Evidence-based treatment of multiple myeloma with a focus on quality of life and long-term control.
మల్టిపుల్ మైలోమా చికిత్సలో అనుభవం.
Personalized therapy for breast, lung, gastrointestinal, genitourinary and head & neck cancers.
బ్రెస్ట్, ఊపిరితిత్తులు, జీర్ణనాళ క్యాన్సర్ చికిత్స.
Autologous, matched sibling, and haploidentical transplants for blood cancers.
బోన్ మారో ట్రాన్స్ప్లాంట్లతో ఎన్నోఏళ్ల అనుభవం.
Advanced cellular therapy for refractory leukemia and lymphoma in select patients.
సెల్ థెరపీ (CAR-T) లో నైపుణ్యం.
Focused treatment of childhood leukemias and lymphomas, balancing cure with care.
Relief from cancer symptoms, pain, and side effects through personalized care planning.
పాలియేటివ్ కేర్ మరియు సపోర్టివ్ ట్రీట్మెంట్ నైపుణ్యం.
Selected peer-reviewed research in hematology, oncology, and stem cell transplantation
Mutation analysis in CML patients who failed imatinib, guiding next-line tyrosine kinase inhibitor selection.
BloodLong-term outcomes and late effects in South Indian children with Hodgkin lymphoma.
Annals of OncologyReal-world evidence on whether early PET response predicts Hodgkin lymphoma outcome.
JCO Global OncologyDosage modifications and outcomes in high-risk APL with triple therapy (ATRA, ATO, daunorubicin).
JCO Global OncologyData from this work was presented as an oral presentation at the American Society of Hematology (ASH) Annual Meeting, 2015.
Cost-effectiveness and survival outcomes with generic imatinib in CML.
Clinical Lymphoma Myeloma and LeukemiaSouth Indian multicenter study comparing BCR-ABL1 halving time with day-90 response in CML.
Clinical Lymphoma Myeloma and LeukemiaEight-year experience treating Ph+ ALL at a tertiary cancer center in India.
South Asian Journal of CancerAdiponectin, leptin, and their ratio as potential risk biomarkers in obesity-related breast cancer.
Indian Journal of Medical and Paediatric OncologyFive-year experience with peptide receptor radionuclide therapy in neuroendocrine tumors.
European Journal of Nuclear Medicine and Molecular Imaging